famotidine has been researched along with Weight Gain in 5 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Olanzapine treatment is associated with substantial weight gain." | 9.11 | The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study. ( Fuchs, C; Gil-Ad, I; Maayan, R; Poyurovsky, M; Tal, V; Weizman, A, 2004) |
| "There is low-certainty evidence to suggest that metformin may be effective in preventing weight gain." | 5.22 | Pharmacological interventions for prevention of weight gain in people with schizophrenia. ( Agarwal, SM; Ahsan, ZA; Cohn, T; Duncan, MJ; Faulkner, GEJ; Hahn, M; Lockwood, JT; Remington, G; Stogios, N; Takeuchi, H; Taylor, VH, 2022) |
| "Olanzapine treatment is associated with substantial weight gain." | 5.11 | The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study. ( Fuchs, C; Gil-Ad, I; Maayan, R; Poyurovsky, M; Tal, V; Weizman, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, SM | 1 |
| Stogios, N | 1 |
| Ahsan, ZA | 1 |
| Lockwood, JT | 1 |
| Duncan, MJ | 1 |
| Takeuchi, H | 1 |
| Cohn, T | 1 |
| Taylor, VH | 1 |
| Remington, G | 1 |
| Faulkner, GEJ | 1 |
| Hahn, M | 1 |
| Okada, K | 1 |
| Yajima, K | 1 |
| Ohba, T | 1 |
| Miyazaki, T | 1 |
| Orihashi, T | 1 |
| Sato, S | 1 |
| Yasuda, J | 1 |
| Poyurovsky, M | 1 |
| Tal, V | 1 |
| Maayan, R | 1 |
| Gil-Ad, I | 1 |
| Fuchs, C | 1 |
| Weizman, A | 1 |
| Onose, J | 1 |
| Imai, T | 1 |
| Hasumura, M | 1 |
| Ueda, M | 1 |
| Ozeki, Y | 1 |
| Hirose, M | 1 |
| Støa-Birketvedt, G | 1 |
| Løvhaug, N | 1 |
| Vonen, B | 1 |
| Florholmen, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Comparison of Bupropion SR and Placebo for Smoking Cessation[NCT00176449] | Phase 4 | 52 participants (Actual) | Interventional | 2001-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for famotidine and Weight Gain
| Article | Year |
|---|---|
Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Topics: Antipsychotic Agents; Betahistine; Famotidine; Fluoxetine; Humans; Melatonin; Metformin; Nausea; Niz | 2022 |
1 trial available for famotidine and Weight Gain
| Article | Year |
|---|---|
The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Double-Blind Method; Drug Interaction | 2004 |
3 other studies available for famotidine and Weight Gain
| Article | Year |
|---|---|
The effect of experimental inhibition of gastric acid secretion on curd formation in abomasum and weight gain of calves.
Topics: Abomasum; Animal Husbandry; Animal Nutritional Physiological Phenomena; Animals; Animals, Suckling; | 2010 |
Evaluation of subchronic toxicity of dietary administered Cry1Ab protein from Bacillus thuringiensis var. Kurustaki HD-1 in F344 male rats with chemically induced gastrointestinal impairment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bacillus thuringiensis; Bacillu | 2008 |
H2-receptor antagonist reduces food intake and weight gain in rats by non-gastric acid secretory mechanisms.
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Eating; Famotidine; Gastric Acid; Histamine H2 Antagonists; | 1997 |